search
Back to results

Postoperative Artificial Nutrition After Pancreaticoduodenectomy (Nutri-DPC)

Primary Purpose

Pancreatic Disease

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Total parenteral nutrition
Enteral nutrition
Sponsored by
Hospices Civils de Lyon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pancreatic Disease focused on measuring postoperative artificial nutrition, parenteral nutrition, enteral nutrition, postoperative complications, cephalic pancreatoduodenectomy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Male or female patients more than 18 years of age.
  • Pancreatic surgery by pancreaticoduodenectomy.
  • Patient affiliated to a mode of the social security or receiving of such a mode.
  • Having given written informed consent prior to any procedure related to the study

Exclusion Criteria:

  • ASA score ≥4
  • Pregnant women
  • Patient who cannot give written informed consent.
  • Concomitant participation in a biomedical study being able to interfere with this research
  • Patient less than 18 years of age or more than 18 years of age, protected by the Law, under guardianship

Sites / Locations

  • Unité de Chirurgie Hépatobiliaire et Pancréatique Hopital Edouard HerriotRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

total parenteral nutrition

Early enteral nutrition

Arm Description

Outcomes

Primary Outcome Measures

Percentage of patients presenting one or several postoperative complications
Data recorded during the period of hospitalization (an expected average of 3 weeks) and until control visit 3 months after surgery

Secondary Outcome Measures

Nutritional status
weight, BMI, Index of Nutritional Risk, blood albumin and prealbumin, during the period of hospitalization (an expected average of 3 weeks) and until control visit 3 months after surgery
Infectious complications
Percentage of patients presenting an infectious complication, and type of infectious complication
Evaluation of the severity of the complications
according to classification of Dindo-Clavien
Pancreatic fistulas
evaluation of the occurrence of pancreatic fistulas, grade B and C, in both groups of patients
Hemorrhagic complications
evaluation of the occurrence of hemorrhagic complications, grade B and C, in both groups of patients
gastroparesis
defined as the presence of the nasogastric probe 10 days after the surgery
Duration of hospital stay
Time frame of resumption of the intestinal bowel motion
daytime of resumption of flatulencies and\or stools
Time frame of resumption of the oral food and artificial nutrition weaning

Full Information

First Posted
January 31, 2012
Last Updated
April 17, 2012
Sponsor
Hospices Civils de Lyon
search

1. Study Identification

Unique Protocol Identification Number
NCT01580527
Brief Title
Postoperative Artificial Nutrition After Pancreaticoduodenectomy
Acronym
Nutri-DPC
Official Title
A Prospective, Multicentric, Randomized Trial Comparing Early Enteral Nutrition Versus Parenteral Nutrition After Pancreaticoduodenectomy
Study Type
Interventional

2. Study Status

Record Verification Date
April 2012
Overall Recruitment Status
Unknown status
Study Start Date
March 2011 (undefined)
Primary Completion Date
March 2014 (Anticipated)
Study Completion Date
March 2014 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Pancreaticoduodenectomy is a major surgery burdened by important morbidity and mortality partially related to the altered nutritional status of the patients. The perioperative malnutrition is a major risk factor of postoperative complications and worsens the prognosis of the patients. The perioperative artificial nutrition has for objectives to correct the preoperative malnutrition, and to maintain the nutritional status in the post-operative period. The current guidelines in surgery are in favour of a realisation of a perioperative artificial nutrition support that privilege the enteral nutrition. However, after pancreaticoduodenectomy, the total parenteral nutrition remains most usually used in the early postoperative period, although rare studies suggest a benefit of the enteral nutrition in term of reduction of the post-operative complications. Indeed, no recommendation was formulated concerning early enteral nutrition after pancreaticoduodenectomy because few studies were realized on its profits. The data of the literature report rates of complications (essentially major) from 49 % to 59 % after major digestive surgery (not only pancreatic) on patients having received a total parenteral nutrition versus rates from 34 to 43.8 % in patients having received an early enteral nutrition. A preliminary prospective study realized in the investigators centre showed a rate of 74 % complication versus 44 %, respectively in the total parenteral nutrition and early enteral nutrition groups (50 patients in every group, with p < 0.01. All the complications were listed prospectively). Hypothesis : The early enteral nutrition will allow, after pancreaticoduodenectomy, a decrease of, at least, 19 % complications of any stage according to the classification of Dindo-Clavien (59 % versus 40 %).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pancreatic Disease
Keywords
postoperative artificial nutrition, parenteral nutrition, enteral nutrition, postoperative complications, cephalic pancreatoduodenectomy

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
220 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
total parenteral nutrition
Arm Type
Active Comparator
Arm Title
Early enteral nutrition
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Total parenteral nutrition
Intervention Description
Total parenteral nutrition in postoperative of pancreaticoduodenectomy
Intervention Type
Procedure
Intervention Name(s)
Enteral nutrition
Intervention Description
Early enteral nutrition in postoperative of pancreaticoduodenectomy
Primary Outcome Measure Information:
Title
Percentage of patients presenting one or several postoperative complications
Description
Data recorded during the period of hospitalization (an expected average of 3 weeks) and until control visit 3 months after surgery
Time Frame
90 days
Secondary Outcome Measure Information:
Title
Nutritional status
Description
weight, BMI, Index of Nutritional Risk, blood albumin and prealbumin, during the period of hospitalization (an expected average of 3 weeks) and until control visit 3 months after surgery
Time Frame
90 days
Title
Infectious complications
Description
Percentage of patients presenting an infectious complication, and type of infectious complication
Time Frame
within the hospitalization time after surgery (an expected average of 3 weeks)
Title
Evaluation of the severity of the complications
Description
according to classification of Dindo-Clavien
Time Frame
within the hospitalization time after the surgery (an expected average of 3 weeks)
Title
Pancreatic fistulas
Description
evaluation of the occurrence of pancreatic fistulas, grade B and C, in both groups of patients
Time Frame
within the hospitalization time after the surgery (an expected average of 3 weeks)
Title
Hemorrhagic complications
Description
evaluation of the occurrence of hemorrhagic complications, grade B and C, in both groups of patients
Time Frame
within the hospitalization time after the surgery (an expected average of 3 weeks)
Title
gastroparesis
Description
defined as the presence of the nasogastric probe 10 days after the surgery
Time Frame
within the hospitalization time after the surgery (an expected average of 3 weeks)
Title
Duration of hospital stay
Time Frame
within the hospitalization time after the surgery (an expected average of 3 weeks)
Title
Time frame of resumption of the intestinal bowel motion
Description
daytime of resumption of flatulencies and\or stools
Time Frame
within the hospitalization time after the surgery (an expected average of 3 weeks)
Title
Time frame of resumption of the oral food and artificial nutrition weaning
Time Frame
within the hospitalization time after the surgery (an expected average of 3 weeks)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male or female patients more than 18 years of age. Pancreatic surgery by pancreaticoduodenectomy. Patient affiliated to a mode of the social security or receiving of such a mode. Having given written informed consent prior to any procedure related to the study Exclusion Criteria: ASA score ≥4 Pregnant women Patient who cannot give written informed consent. Concomitant participation in a biomedical study being able to interfere with this research Patient less than 18 years of age or more than 18 years of age, protected by the Law, under guardianship
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mustapha ADHAM, Professor
Phone
+33 4 72 11 62.61
Email
mustapha.adham@chu-lyon.fr
Facility Information:
Facility Name
Unité de Chirurgie Hépatobiliaire et Pancréatique Hopital Edouard Herriot
City
LYON cedex 03
ZIP/Postal Code
69437
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mustapha ADHAM, Professor

12. IPD Sharing Statement

Learn more about this trial

Postoperative Artificial Nutrition After Pancreaticoduodenectomy

We'll reach out to this number within 24 hrs